Cancer deaths rose to 10 million and new cases jumped to over 23 million globally in 2019, according to a new scientific study from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine. At the start of the decade in 2010, total cancer deaths numberedContinue Reading
Recovering elective and cancer care performance to the standards required will be a huge and lengthy challenge for the NHS, and there is a real risk that the waiting list for patients seeking elective care will be longer in 2025 than it is today, according to analysis from the NationalContinue Reading
Public Service Campaign with Music Icon Patti LaBelle Connects Floridians With Resources to Schedule Medical Appointments for Early Cancer Detection Millions of people delayed medical care during the COVID-19 pandemic. Local oncologists are participating in a new initiative encouraging Floridians to schedule potentially lifesaving cancer screenings. Led by two nationalContinue Reading
An innovative procedure proven to minimize potential side effects for prostate cancer patients who receive radiation therapy is now offered exclusively in Ocala and The Villages by Florida Cancer Specialists & Research Institute (FCS) radiation oncologists Dr. Sachin Kamath and Dr. Luis Carrascosa. The pre-treatment option, known as SpaceOAR™ Hydrogel, is the first and only FDA-clearedContinue Reading
Florida Cancer Specialists & Research Institute (FCS) welcomes Board-certified gynecologic oncologist Jessica Stine, MD. She is caring for patients at the FCS New Port Richey location at 8763 River Crossing Blvd., New Port Richey, FL and in Wesley Chapel at 2391 Oak Myrtle Lane, Wesley Chapel, FL. After earning her medical degree from theContinue Reading
The U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system. Laverdia-CA1 works to prevent certain proteins from leaving the nucleus of cancer cells, thereby allowing these proteins to control the growth and preventContinue Reading
On Friday, the US Food and Drug Administration (FDA) approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer. “Today’s approval marks the first oral drug in this class and it may eliminate some patients’ need to visit the clinic for treatments that require administration by a healthContinue Reading
Since June 2016, Florida Cancer Specialists & Research Institute (FCS) has participated in the Oncology Care Model (OCM), a national innovative payment program designed to lower the costs of cancer care nationwide, while maintaining high-quality enhanced services to Medicare beneficiaries. Established by the Centers for Medicare & Medicaid Innovation (CMMI), a divisionContinue Reading
At the request of former Board Chair Brad Prechtl and his wife Terri, the Florida Cancer Specialists Foundation (FCSF) is transferring all proceeds from the Brad & Terri Prechtl Fund to a newly-created special fund for immediate financial assistance to cancer patients who have been affected by COVID-19. The FCS Foundation is a 501(c)3 nonprofit organization thatContinue Reading
Florida Cancer Specialists & Research Institute (FCS) is seeking to reduce deaths and suffering from hereditary cancers with the launch of a cancer genetics program across its statewide practice. The use of a powerful and proven technology tool developed by Chicago-based software and data analytics company, CancerIQ, and the addition of a specially-trainedContinue Reading
Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. One in four new leukemia cases are CLL. Early-stage CLL patients often do not require therapy, but for those with aggressive disease or who have failed previous treatments, a targeted therapy approach may be necessary. One such targeted therapyContinue Reading
Lucio Gordan, MD, President and Managing Physician of Florida Cancer Specialists Research & Institute (FCS), will lead an educational session at the Community Oncology Advocacy Summit, a national virtual meeting presented by the Community Oncology Alliance (COA). Scheduled for July 15, 2020, the one-day virtual conference will focus on patient advocacy and the impact ofContinue Reading
Florida Cancer Specialists & Research Institute (FCS) recently celebrated the start of construction of its new Trinity Cancer Center. When complete in early 2021, the 37,000 square foot facility will include radiation oncology and next-generation PET/CT imaging technology along with 27 exam rooms and 52 chairs for chemotherapy and other infusions.Continue Reading
The state of Florida, as well as the cities of Boynton Beach, Coral Gables, Fort Myers, Melbourne, Ocala, Tarpon Springs, and West Palm Beach, have issued proclamations celebrating men’s health and fatherhood in June, helping educate men, boys, and their families about disease prevention, timely screenings, healthy lifestyles, and positiveContinue Reading
Florida Cancer Specialists & Research Institute (FCS) is pleased to announce the opening of a new office location in Middleburg, Florida on June 1, 2020. FCS currently has a clinic location in Fleming Island, making the Middleburg site its second location in the greater Jacksonville area. Located at 1658 St. Vincent’s Way, Suite 340,Continue Reading
Despite the many challenges of the current health care crisis, patients of Florida Cancer Specialists & Research Institute (FCS) report high satisfaction with the oncology provider’s response and efforts to provide care safely, and with little or no disruption. In a survey of over 3,000 patients, conducted earlier this month by anContinue Reading
Memorial Day — long considered the unofficial start of summer in the U.S. — is quickly approaching, and dermatologists from the American Academy of Dermatology are urging Americans to practice safe sun as they head outdoors, especially as shelter-in-place measures related to COVID-19 begin to lift. Skin cancer is theContinue Reading
Florida Cancer Specialists & Research Institute (FCS) offers an advanced radiation therapy option for several types of cancers, which can lead to faster and shorter rounds of radiation therapy for patients. Hypofractionated radiation is a treatment technique where the total dose of radiation is delivered in fewer treatment sessions and resultsContinue Reading
Florida Cancer Specialists & Research Institute (FCS) is pleased to welcome Medical Oncologist Martin F. Dietrich, MD, PhD. He is serving patients at the FCS Lake Mary Cancer Center at 805 Currency Circle, Lake Mary, FL and at 2572 W SR 426, Suite 3080, in Oviedo, FL. Dr. Dietrich isContinue Reading
Florida Cancer Specialists & Research Institute (FCS) and Cedar, a patient engagement and payment technology platform, today announced that they are partnering to modernize the on-line payment experience for FCS patients. “This partnership with Cedar enables us to keep pace with the rapid technology advances in the healthcare industry and improve theContinue Reading
Patients with advanced melanoma who develop metastases in the leptomeninges, the fluid filled membranes surrounding the brain and spinal cord, have an extremely dismal prognosis. Most patients only survive for 8 to 10 weeks after diagnosis. One reason for this poor prognosis is that very little information is known aboutContinue Reading
